{"title":"通过骨遗传疾病重新审视与药物相关的颌骨骨坏死:我们知道什么?","authors":"M. Fénelon, J. Fricain","doi":"10.1051/MBCB/2021015","DOIUrl":null,"url":null,"abstract":"Today, oral surgeons routinely meet bone complications in patients receiving anti-resorptive treatments. Bisphosphonates and Denosumab are both osteoclast-targeted anti-resorptive therapy which may cause osteonecrosis of the jaw, also known as Medication-Related Osteonecrosis of Jaws (MRONJ)","PeriodicalId":37322,"journal":{"name":"Journal of Oral Medicine and Oral Surgery","volume":"1 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Medication-related osteonecrosis of jaws revisited through the bone inherited disorders: what do we know?\",\"authors\":\"M. Fénelon, J. Fricain\",\"doi\":\"10.1051/MBCB/2021015\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Today, oral surgeons routinely meet bone complications in patients receiving anti-resorptive treatments. Bisphosphonates and Denosumab are both osteoclast-targeted anti-resorptive therapy which may cause osteonecrosis of the jaw, also known as Medication-Related Osteonecrosis of Jaws (MRONJ)\",\"PeriodicalId\":37322,\"journal\":{\"name\":\"Journal of Oral Medicine and Oral Surgery\",\"volume\":\"1 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Oral Medicine and Oral Surgery\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1051/MBCB/2021015\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"Dentistry\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Oral Medicine and Oral Surgery","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1051/MBCB/2021015","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Dentistry","Score":null,"Total":0}
Medication-related osteonecrosis of jaws revisited through the bone inherited disorders: what do we know?
Today, oral surgeons routinely meet bone complications in patients receiving anti-resorptive treatments. Bisphosphonates and Denosumab are both osteoclast-targeted anti-resorptive therapy which may cause osteonecrosis of the jaw, also known as Medication-Related Osteonecrosis of Jaws (MRONJ)
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
